From 2024 to 2028, the forecasted use of cardiovascular system medicine in Austria shows a consistent decline in Units (Defined Daily Dosage) Per Thousand Persons Per Day. The values decrease from 306.7 in 2024 to 295.2 in 2028.
Year-on-year variation for this period is as follows:
- 2024 to 2025: -0.95%
- 2025 to 2026: -0.95%
- 2026 to 2027: -0.97%
- 2027 to 2028: -0.94%
Over the last two years, the average variation was steady at approximately -0.965% per year. The Compound Annual Growth Rate (CAGR) from 2023 to 2028 is projected to be around -0.94% per year, indicating a slight but consistent decline.
Future trends to watch for include advancements in medical technology, changing demographic health profiles, and policy changes regarding healthcare. Additionally, the impact of new treatment guidelines and preventive measures will be crucial in shaping the future demand for cardiovascular medicines.
